Urs Frey, MaxWell Bio Systems
Cell imaging patform to accelerate drug discovery.
MaxWell Biosystems AG provides a label-free cell-imaging platform to assess the clinical potential of brain drugs with high precision. Their micro-electrode array (MEA) technology can augment and complement high-content imaging systems by providing functional, electro- physiological readouts. Their technology, which is based on micro-sensor fabricated in CMOS technology, enables readouts with high signal quality, high resolution, and high throughput.